gemcitabine has been researched along with colchicine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Arif, T; Barbarat, B; Borie, C; Briand, M; Dumur, F; Gigmes, D; Lingua, H; Maresca, M; Mondal, S; Nechab, M; Nicoletti, C; Olive, D; Robert, V; Stocker, P | 1 |
| Guan, Q; Huang, M; Li, L; Li, M; Liu, R; Sun, J; Wu, L; Zhang, S; Zhang, W | 1 |
| Apers, S; Capistrano, R; Dockx, Y; Lardon, F; Pauwels, P; Pieters, L; Staelens, S; Stroobants, S; Vangestel, C; Wouters, A | 1 |
| Apers, S; Capistrano I, R; Fransen, E; Pieters, L; Staelens, S; Vangestel, C; Vanpachtenbeke, H | 1 |
| Chang, A; Gao, S; Ge, Y; Hao, J; Huang, C; Li, H; Liu, J; Sun, H; Wang, X; Wang, Y; Wu, L; Xu, C; Yuan, Y; Zhao, T | 1 |
1 review(s) available for gemcitabine and colchicine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for gemcitabine and colchicine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Enediynes bearing polyfluoroaryl sulfoxide as new antiproliferative agents with dual targeting of microtubules and DNA.
Topics: Antineoplastic Agents; Cell Line, Tumor; DNA; DNA Breaks, Double-Stranded; Enediynes; Humans; Microtubules; Sulfoxides; Ultraviolet Rays | 2018 |
Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Imidazoles; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Molecular Structure; Polymerization; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2021 |
Efficacy Screening of Gloriosa Superba Extracts in a Murine Pancreatic Cancer Model Using (18)F-FDG PET/CT for Monitoring Treatment Response.
Topics: Animals; Antimetabolites, Antineoplastic; Colchicine; Deoxycytidine; Drug Synergism; Female; Fluorodeoxyglucose F18; Gemcitabine; High-Throughput Screening Assays; Humans; Immunoenzyme Techniques; Liliaceae; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms; Plant Extracts; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Seeds; Toxicity Tests, Acute; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |
Coadministration of a Gloriosa superba extract improves the in vivo antitumoural activity of gemcitabine in a murine pancreatic tumour model.
Topics: Alkaloids; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Colchicine; Deoxycytidine; Disease Models, Animal; Female; Gemcitabine; Glycosides; Herb-Drug Interactions; Humans; Liliaceae; Mice, Inbred C57BL; Pancreas; Pancreatic Neoplasms; Phytotherapy; Plant Extracts; Seeds | 2016 |
Genome-wide CRISPR screen identifies MTA3 as an inducer of gemcitabine resistance in pancreatic ductal adenocarcinoma.
Topics: Animals; Carcinoma, Pancreatic Ductal; Carrier Proteins; Cell Line, Tumor; Colchicine; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; LIM Domain Proteins; Mice; Neoplasm Proteins; NF-kappa B; Nucleosomes; Pancreatic Neoplasms; Xenograft Model Antitumor Assays | 2022 |